Article Text

PDF
Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention
  1. Charlotte R Hedin1,2,
  2. Andrew J Stagg2,
  3. Kevin Whelan1,
  4. James O Lindsay3
  1. 1King's College London, School of Medicine, Diabetes and Nutritional Sciences Division, London, UK
  2. 2Centre for Immunology and Infectious Disease, Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, UK
  3. 3Digestive Disease Clinical Academic Unit, Barts and the London NHS Trust, London, UK
  1. Correspondence to Dr James O Lindsay, Barts and the London NHS Trust, Endoscopy Unit, The Royal London Hospital, Whitechapel, London E1 1BB, UK; james.lindsay{at}bartsandthelondon.nhs.uk

Abstract

Crohn's disease (CD) is an incurable intestinal disorder in which the loss of immune tolerance to the commensal gut microbiota leads to chronic inflammation. The reason this occurs in specific individuals is unclear; however, a genetic predisposition is fundamental and relatives of patients with CD are at significant risk of developing the disease. Knowledge relating to the genetic loci that predispose to CD is accumulating, which raises the possibility of disease prediction and prevention in susceptible populations. However, the genetic basis of CD is complex and genotyping alone is likely to be insufficient to predict disease risk accurately. Specific physiological abnormalities associated with CD, such as increased intestinal permeability and raised faecal calprotectin, are also abnormal in some relatives of patients with CD. The combination of genotypic factors and biomarkers of risk makes the development of models of disease prediction a realistic possibility. Furthermore, enhanced understanding of the genotype and phenotype of the at-risk state in relatives of patients with CD allows the earliest stages in the pathogenesis of CD to be investigated and may allow intervention to prevent disease onset. This article reviews current knowledge of the at-risk phenotype in relatives of patients with CD and focuses on the implications for the design of future studies.

  • Crohn's disease
  • family
  • siblings
  • risk
  • primary prevention
  • gut immunology
  • intestinal microbiology
  • intestinal permeability
  • stool markers

Statistics from Altmetric.com

Footnotes

  • Funding CRH is a clinical research fellow funded by Core.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.